Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to dimdazenil in insomnia patients dissatisfied with non-benzodiazepine hypnotics
CTR20242524Phase 4Active
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimdazenil in Insomnia, sponsored by Hengrui Therapeutics. Started Oct 2024; status: active.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20242524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242524.